(Q50105130)

25 February 2018

title

Development of a mucosal complex vaccine against oral Salmonella infection in mice. (English)

1 reference

25 February 2018

author name string

Hiroko Harada

1

1 reference

25 February 2018

Fumiko Nishikawa

2

1 reference

25 February 2018

Nobutaka Higashi

3

1 reference

25 February 2018

Eiji Kita

4

1 reference

25 February 2018

publication date

1 January 2002

1 reference

25 February 2018

Microbiology and Immunology

published in

1 reference

25 February 2018

volume

46

1 reference

25 February 2018

issue

12

1 reference

25 February 2018

page(s)

891-905

1 reference

25 February 2018

Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Isolation and purification of human large bowel mucosal lymphoid cells: effect of separation technique on functional characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium III. Analysis of resistance induced by dialyzable factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2002.TB02778.X

10.1111/J.1348-0421.2002.TB02778.X

21 January 2018

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018